跳转至内容
Merck
CN
  • Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes.

Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes.

Biochemical and biophysical research communications (2015-11-08)
Kyeongah Kang, Sorim Nam, Bomi Kim, Ji Hyun Lim, Young Yang, Myeong-Sok Lee, Jong-Seok Lim
摘要

N-Myc downstream-regulated gene 2 (NDRG2), a member of the NDRG family of differentiation-related genes, has been characterized as a regulator of dendritic cell differentiation from monocytes, CD34(+) progenitor cells, and myelomonocytic leukemic cells. In this study, we show that NDRG2 overexpression inhibits the differentiation of U937 cells into osteoclasts in response to stimulation with a combination of macrophage colony-stimulating factor (M-CSF) and soluble receptor activator of NF-κB ligand (RANKL). U937 cells stably expressing NDRG2 are unable to differentiate into multinucleated osteoclast-like cells and display reduced tartrate-resistant acid phosphatase (TRAP) activity and resorption pit formation. Furthermore, NDRG2 expression significantly suppresses the expression of genes that are crucial for the proliferation, survival, differentiation, and function of osteoclasts, including c-Fos, Atp6v0d2, RANK, and OSCAR. The activation of ERK1/2 and p38 is also inhibited by NDRG2 expression during osteoclastogenesis, and the inhibition of osteoclastogenesis by NDRG2 correlates with the down-regulation of the expression of the transcription factor PU.1. Taken together, our results suggest that the expression of NDRG2 potentially inhibits osteoclast differentiation and plays a role in modulating the signal transduction pathway responsible for osteoclastogenesis.

材料
货号
品牌
产品描述

Sigma-Aldrich
凝血酶受体激动剂, ≥97% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human NDRG2